NASDAQ:BCRX | Cash Flow Statement | BIOCRYST PHARMACEUTICALS INC

Complete source-backed cash-flow history.

Available history
2009-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30$78.4M
2026-03-31-$721.81M-$61.79M-$268.65M$412.55M
2025-12-31$245.85M$394,000.00$291.96M-$83.49M-$217.96M
2025-09-30$12.9M
2025-06-30$5.09M
2025-03-31$32,000.00$331,000.00-$27.52M$27.1M$529,000.00
2024-12-31-$26.8M$309,000.00-$5.21M$17.8M-$4.02M
2024-09-30-$14.03M
2024-06-30-$12.67M
2024-03-31-$35.38M$306,000.00-$53.68M$28.76M-$1.05M
2023-12-31-$61.73M$423,000.00-$8.92M-$28.47M-$3.17M
2023-09-30-$36.15M
2023-06-30-$75.33M
2023-03-31-$53.33M$405,000.00-$47.51M-$107.11M$5.08M
2022-12-31-$71.54M$396,000.00-$23.85M$77.22M$4.2M
2022-09-30-$42.52M
2022-06-30-$58.86M
2022-03-31-$74.2M$317,000.00-$77.8M-$38.47M$7.36M
2021-12-31-$17.78M$171,000.00-$32.46M-$11.12M$347.42M
2021-09-30-$58.8M
2021-06-30-$43.2M
2021-03-31-$64.28M$178,000.00-$61.01M$14.67M$2.9M
2020-12-31-$60.49M$180,000.00-$42.53M$21.41M$196.76M
2020-09-30-$46.12M
2020-06-30-$38.61M
2020-03-31-$37.6M$218,000.00-$23.28M$10.72M$266,000.00
2019-12-31-$2.62M$185,000.00-$10.45M$16.26M$78.46M
2019-09-30-$37.59M
2019-06-30-$37.63M
2019-03-31-$31.05M$176,000.00-$27M$15.88M$20.04M
2018-12-31-$27.43M$198,000.00-$23.99M-$3.17M$1.34M
2018-09-30-$29.6M
2018-06-30-$18.45M
2018-03-31-$25.78M$186,000.00-$19.65M$15.93M-$1.48M
2017-12-31-$19.54M$182,000.00-$10.52M-$57.38M$573,000.00
2017-09-30-$15.13M
2017-06-30-$16.89M
2017-03-31-$14.22M$172,000.00-$8.53M$14.13M$48.7M
2016-12-31-$4.5M$172,000.00-$5.85M-$9.83M$2.33M
2016-09-30-$11.53M
2016-06-30-$16.28M
2016-03-31-$22.83M$47,000.00-$18.84M
2015-12-31-$18.14M$43,000.00-$14.83M
2015-09-30-$14.62M
2015-06-30$4.9M
2015-03-31-$15.16M$45,000.00-$3.73M
2014-12-31-$11.67M$40,000.00-$13.89M
2014-09-30-$8.73M
2014-06-30-$14.65M
2014-03-31-$10.14M$53,000.00-$8.96M-$1.02M$2.4M
2013-12-31-$5.43M$57,000.00-$4.52M-$2.26M$1.89M
2013-09-30-$8M
2013-06-30-$12.17M
2013-03-31-$4.51M$97,000.00-$11.2M$2.07M$3.04M
2012-12-31-$11.05M$167,000.00-$7.03M$3.65M$316,000.00
2012-09-30-$9.7M
2012-06-30-$12.28M
2012-03-31-$6.05M$168,000.00-$12.25M$11.54M$11.93M
2011-12-31-$13.19M$256,000.00-$3.98M-$2.69M$0.00$679,000.00
2011-09-30-$14.46M
2011-06-30-$16.27M
2011-03-31-$13.03M-$14.33M$7.76M$61,000.00$24.29M
2010-12-31-$10.2M$1.17M-$5.82M$8.12M$1,000.00$145,000.00
2010-09-30-$10.86M
2010-06-30-$10.19M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31$263.86M$1.39M$347.37M-$13.69M-$349.93M
2024-12-31-$88.88M$1.25M-$52.02M$52.59M-$5.76M
2023-12-31-$226.54M$1.66M-$95.14M-$131.5M$32.49M
2022-12-31-$247.12M$1.44M-$161.85M-$128.24M$88.03M
2021-12-31-$184.06M$777,000.00-$142.16M$15.8M$359.67M
2020-12-31-$182.81M$748,000.00-$135.11M-$6.86M$300.59M
2019-12-31-$108.9M$724,000.00-$89.58M$343,000.00$77.93M$99.1M
2018-12-31-$101.25M$770,000.00-$92.57M$366,000.00$4.77M$62.5M
2017-12-31-$65.78M$704,000.00-$41.14M$328,000.00-$64.64M$135.7M
2016-12-31-$55.14M$483,000.00-$53.44M$23.27M$23.3M
2015-12-31-$43.02M$180,000.00-$13.12M-$18M$5.48M
2014-12-31-$45.19M$177,000.00-$38.55M
2013-12-31-$30.11M$304,000.00-$26.53M-$3.47M$30.27M
2012-12-31-$39.08M$628,000.00-$37.4M$24.88M$16.96M
2011-12-31-$56.95M$886,000.00-$32.25M$11.32M$61,000.00$23.76M
2010-12-31-$33.85M$2.27M-$28.56M$221,000.00$5,000.00$831,000.00
2009-12-31-$13.45M-$16.22M-$12.9M$155,000.00$47.9M